Literature DB >> 19114096

Scintigraphic evaluation of colon targeting pectin-HPMC tablets in healthy volunteers.

L A Hodges1, S M Connolly, J Band, B O'Mahony, T Ugurlu, M Turkoglu, C G Wilson, H N E Stevens.   

Abstract

The in vivo evaluation of colon-targeting tablets was conducted in six healthy male volunteers. A pectin-hydroxypropyl methylcellulose coating was compressed onto core tablets labelled with 4MBq (99m)Tc-DTPA. The tablets released in the colon in all subjects; three in the ascending colon (AC) and three in the transverse colon (TC). Tablets that released in the TC had reached the AC before or just after food (Group A). The other three tablets released immediately upon AC entry at least 1.5h post-meal (Group B). Release onset for Group B was earlier than Group A (343min vs 448min). Group B tablets exhibited a clear residence period at the ileocaecal junction (ICJ) which was not observed in Group A. Prolonged residence at the ICJ is assumed to have increased hydration of the hydrogel layer surrounding the core tablet. Forces applied as the tablets progressed through the ICJ may have disrupted the hydrogel layer sufficiently to initiate radiolabel release. Conversely, Group A tablets moved rapidly through the AC to the TC, possibly minimising contact times with water pockets. Inadequate prior hydration of the hydrogel layer preventing access of pectinolytic enzymes and reduced fluid availability in the TC may have retarded tablet disintegration and radiolabel diffusion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19114096     DOI: 10.1016/j.ijpharm.2008.12.002

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  7 in total

Review 1.  Biomagnetic methods: technologies applied to pharmaceutical research.

Authors:  Luciana A Corá; Madileine F Américo; Ricardo B Oliveira; Cristina H R Serra; Oswaldo Baffa; Raul C Evangelista; Giselle F Oliveira; José Ricardo Aruda Miranda
Journal:  Pharm Res       Date:  2010-10-15       Impact factor: 4.200

2.  Biopharmaceutical considerations and characterizations in development of colon targeted dosage forms for inflammatory bowel disease.

Authors:  Rajkumar Malayandi; Phani Krishna Kondamudi; P K Ruby; Deepika Aggarwal
Journal:  Drug Deliv Transl Res       Date:  2014-04       Impact factor: 4.617

3.  Direct compression behavior of low- and high-methoxylated pectins.

Authors:  Linda Salbu; Annette Bauer-Brandl; Ingunn Tho
Journal:  AAPS PharmSciTech       Date:  2009-12-15       Impact factor: 3.246

4.  Preparation and gamma scintigraphic evaluation of colon specific pellets of ketoprofen prepared by powder layering technology.

Authors:  M Subhabrota; R Souvik; C Subhadeep
Journal:  Daru       Date:  2011       Impact factor: 3.117

Review 5.  In Vitro Methodologies for Evaluating Colon-Targeted Pharmaceutical Products and Industry Perspectives for Their Applications.

Authors:  Mauricio A García; Felipe Varum; Jozef Al-Gousous; Michael Hofmann; Susanne Page; Peter Langguth
Journal:  Pharmaceutics       Date:  2022-01-26       Impact factor: 6.321

Review 6.  Drug Delivery Systems for the Oral Administration of Antimicrobial Peptides: Promising Tools to Treat Infectious Diseases.

Authors:  Caroline Deshayes; Md Nasir Arafath; Véronique Apaire-Marchais; Emilie Roger
Journal:  Front Med Technol       Date:  2022-01-25

7.  Combination of Pectin and Eudargit RS and Eudragit RL in the Matrix of Pellets Prepared by Extrusion-Spheronization for Possible Colonic Delivery of 5-Amino Salicylic Acid.

Authors:  Abbas Akhgari; Mohammadreza Abbaspour; Meysam Moradkhanizadeh
Journal:  Jundishapur J Nat Pharm Prod       Date:  2013-05-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.